COMP <GO>
NGVT vs LIN // EV/EBITDA & P/E VALUATION
Ingevity Corporation (NYSE) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: NGVT 5
— LIN 6
▲ EV/EBITDA & P/E VALUATION LEADER: NGVT
LAST: $75.37 (+1.62%) • MKT CAP: $2.59B
valuation
6.0x
LAST: $503.15 (-0.99%) • MKT CAP: $231.94B
valuation
18.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NGVT VS. LIN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NGVT | LIN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.50% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 13.10% | +71.90 | NGVT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 6.0x | 18.5x | -12.50 | NGVT | /valuation <GO> |
| Free Cash Flow Yield | 12.78% | 2.19% | +10.59 | NGVT | /fcf-yield <GO> |
| Operating Margin | 35.90% | 26.30% | +9.60 | NGVT | /operating-margins <GO> |
| Net Profit Margin | -14.30% | 20.30% | -34.60 | LIN | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | 3.00% | -5.70 | LIN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.21% | -1.21 | LIN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 3.93 | -1.00 | LIN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | LIN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.0 | 56.6 | +5.42 | NGVT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.01 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 31.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.59B | $231.94B | -$229.35B | LIN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NGVT REV | LIN REV | NGVT GROSS % | LIN GROSS % | NGVT FCF | LIN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.17B | $33.99B | 39.5% | — | $331.2M | $5.09B |
| FY 2024 | $1.20B | $33.01B | 38.7% | — | $128.6M | $4.93B |
| FY 2023 | $1.22B | $32.85B | — | — | $205.1M | $7.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NGVT // BETA —
LIN // BETA 1.01